Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Rheumatoid × baricitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

Methotrexate 4 Abatacept 3 tocilizumab 2 Rituximab 2 tofacitinib 1 secukinumab 1 olokizumab 1 golimumab 1 baricitinib 1 Radioimmunodetection 1 RC-18 1 Etanercept 1 Double-Blind Method 1 Certolizumab Pegol 1 Antirheumatic Agents 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01721044 2019-09-18

RA-BEACON

Eli Lilly and Company

Phase 3 Completed

527 enrolled 37 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡